Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary Shares, par value US$0.0001 per share
-
Shares outstanding
-
37,387,057
-
Total 13F shares
-
115,088
-
Share change
-
+46,153
-
Total reported value
-
$3,870,578
-
Price per share
-
$33.76
-
Number of holders
-
8
-
Value change
-
+$1,586,625
-
Number of buys
-
7
-
Number of sells
-
3
Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q3 2022
As of 30 Sep 2022,
BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
115,088 shares.
The largest 8 holders included
Atria Wealth Solutions, Inc., MORGAN STANLEY, STATE STREET CORP, Qube Research & Technologies Ltd, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, BARCLAYS PLC, and Prestige Wealth Management Group LLC.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.